Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?

The ongoing pandemic Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern in terms of public health Within the symptoms secondary to SARS-CoV-2 infection, hyposmia and anosmia have emerged as characteristic sympt...

Full description

Bibliographic Details
Main Authors: Juan Jose Rodriguez-Sevilla, Roberto Güerri-Fernádez, Bernat Bertran Recasens
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.852998/full
_version_ 1811271560235843584
author Juan Jose Rodriguez-Sevilla
Roberto Güerri-Fernádez
Roberto Güerri-Fernádez
Bernat Bertran Recasens
author_facet Juan Jose Rodriguez-Sevilla
Roberto Güerri-Fernádez
Roberto Güerri-Fernádez
Bernat Bertran Recasens
author_sort Juan Jose Rodriguez-Sevilla
collection DOAJ
description The ongoing pandemic Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern in terms of public health Within the symptoms secondary to SARS-CoV-2 infection, hyposmia and anosmia have emerged as characteristic symptoms during the onset of the pandemic. Although many researchers have investigated the etiopathogenesis of this phenomenon, the main cause is not clear. The appearance of the new variant of concern Omicron has meant a breakthrough in the chronology of this pandemic, presenting greater transmissibility and less severity, according to the first reports. We have been impressed by the decrease in anosmia reported with this new variant and in patients reinfected or who had received vaccination before becoming infected. Based on the literature published to date, this review proposes different hypotheses to explain this possible lesser affectation of smell. On the one hand, modifications in the SARS-CoV-2 spike protein could produce changes in cell tropism and interaction with proteins that promote virus uptake (ACE-2, TMPRSS2, and TMEM16F). These proteins can be found in the sustentacular cells and glandular cells of the olfactory epithelium. Second, due to the characteristics of the virus or previous immunity (infection or vaccination), there could be less systemic or local inflammation that would generate less cell damage in the olfactory epithelium and/or in the central nervous system.
first_indexed 2024-04-12T22:23:14Z
format Article
id doaj.art-b72db46cfcbb4e95838c4a3ddb39a595
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-12T22:23:14Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-b72db46cfcbb4e95838c4a3ddb39a5952022-12-22T03:14:17ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-04-01910.3389/fmed.2022.852998852998Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?Juan Jose Rodriguez-Sevilla0Roberto Güerri-Fernádez1Roberto Güerri-Fernádez2Bernat Bertran Recasens3Hematology Department, Hospital del Mar, Barcelona, SpainInfectious Diseases Department, Hospital del Mar Institute of Medical Research (IMIM), Barcelona, SpainFacultad de Medicina y Ciencias de la Vida (MELIS), Universitat Pompeu Fabra, Barcelona, SpainNeuromuscular Unit, Neurology Department, Hospital del Mar, Barcelona, SpainThe ongoing pandemic Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern in terms of public health Within the symptoms secondary to SARS-CoV-2 infection, hyposmia and anosmia have emerged as characteristic symptoms during the onset of the pandemic. Although many researchers have investigated the etiopathogenesis of this phenomenon, the main cause is not clear. The appearance of the new variant of concern Omicron has meant a breakthrough in the chronology of this pandemic, presenting greater transmissibility and less severity, according to the first reports. We have been impressed by the decrease in anosmia reported with this new variant and in patients reinfected or who had received vaccination before becoming infected. Based on the literature published to date, this review proposes different hypotheses to explain this possible lesser affectation of smell. On the one hand, modifications in the SARS-CoV-2 spike protein could produce changes in cell tropism and interaction with proteins that promote virus uptake (ACE-2, TMPRSS2, and TMEM16F). These proteins can be found in the sustentacular cells and glandular cells of the olfactory epithelium. Second, due to the characteristics of the virus or previous immunity (infection or vaccination), there could be less systemic or local inflammation that would generate less cell damage in the olfactory epithelium and/or in the central nervous system.https://www.frontiersin.org/articles/10.3389/fmed.2022.852998/fullCOVID-19anosmiaOmicron variantinflammationvaccines
spellingShingle Juan Jose Rodriguez-Sevilla
Roberto Güerri-Fernádez
Roberto Güerri-Fernádez
Bernat Bertran Recasens
Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?
Frontiers in Medicine
COVID-19
anosmia
Omicron variant
inflammation
vaccines
title Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?
title_full Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?
title_fullStr Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?
title_full_unstemmed Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?
title_short Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?
title_sort is there less alteration of smell sensation in patients with omicron sars cov 2 variant infection
topic COVID-19
anosmia
Omicron variant
inflammation
vaccines
url https://www.frontiersin.org/articles/10.3389/fmed.2022.852998/full
work_keys_str_mv AT juanjoserodriguezsevilla istherelessalterationofsmellsensationinpatientswithomicronsarscov2variantinfection
AT robertoguerrifernadez istherelessalterationofsmellsensationinpatientswithomicronsarscov2variantinfection
AT robertoguerrifernadez istherelessalterationofsmellsensationinpatientswithomicronsarscov2variantinfection
AT bernatbertranrecasens istherelessalterationofsmellsensationinpatientswithomicronsarscov2variantinfection